C-Y Chen

发表

LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas

L. Tsai, P-M Chen, Y. Cheng, 2014, Oncogene.

Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.

B. Haynes, W. Jacobs, N. Letvin, 2008, The Journal of infectious diseases.

Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells

C-Y Chen, T. Zhu, Z. Xiao, 2007, British Journal of Cancer.

Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancer

C-Y Chen, T. Zhu, Z. Xiao, 2006, British Journal of Cancer.

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

C-Y Chen, H. Ying, W. Qiu, 2007, Oncogene.

Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression

Y. Cheng, C-Y Chen, T. Wu, 2014, Oncogene.

Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis

M. Kahn, Lei He, K. Machida, 2017, Oncogene.

Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers

Y. Cheng, C-Y Chen, T. Wu, 2007, Oncogene.

Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case–control study for risk assessment

C-Y Chen, Chein-Hui Hung, H. Hsu, 2007, The Journal of pathology.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2017, Oncogene.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2014, Oncogene.

Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma

C-Y Chen, H. Lee, K. Tsai, 2000, British Journal of Cancer.

DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

Y. Cheng, C-Y Chen, H. Lee, 2014, Oncogene.

Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability

C-Y Chen, H. Lee, De-Wei Wu, 2016, Oncogene.

GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug

A. Nesvizhskii, Yih-Leong Chang, C-Y Chen, 2014, Oncogene.

Retinoblastoma protein modulates gankyrin–MDM2 in regulation of p53 stability and chemosensitivity in cancer cells

C-Y Chen, J. Fujita, W. Qiu, 2008, Oncogene.

The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss

L. Tsai, Y. Cheng, C-Y Chen, 2014, Oncogene.

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT

Y. Cheng, C-Y Chen, H. Lee, 2014, Oncogene.

CUL4A promotes the invasion of cervical cancer cells by regulating NF-κB signaling pathway.

C-Y Chen, Ye Lin, Q. Mei, 2020, European review for medical and pharmacological sciences.

Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-κB activation

Y. Cheng, C-Y Chen, T. Wu, 2010, Oncogene.

GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug

C-Y Chen, T. Hong, Y.-Y. Wu, 2017, Oncogene.

Poster session 2

Hugo A. Katus, V. V. Miroshnikova, Paolo Dario, 2004, EP Europace.

Prognostic significance of p53 codon 72 polymorphism in lung carcinomas.

C-Y Chen, C. Y. Chen, H. Lee, 1999, European journal of cancer.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2015, Oncogene.